Market Access

Showing 15 posts of 19 posts found.

Is this an Oppenheimer moment for the life sciences industry?

October 29, 2025 Business Services, Market Access, Market Access Consultancy, Sales and Marketing NHS, Visions4Health

By Sabina Syed, Managing Director at Visions4Health In the history of science, few initiatives demonstrate the magnitude of coordinated effort …

Turning a 10-Year Vision into a 10-Year Plan

October 27, 2025 Business Services, Market Access, Market Access Consultancy Corporate, Gateway to Local Adoption, NHS, Pharmacy, Population Health Management, Visions4Health, pharmacy

In the sixth of the Gateway to Local Adoption series, Visions4Healthโ€™s Head of Client Services, Jonny Savage, shares his views …

From sickness to prevention: the case for population health management

October 3, 2025 Business Services, Market Access, Market Access Consultancy Corporate, Gateway to Local Adoption, NHS, Pharmacy, Population Health Management, Visions4Health, pharmacy

In the third of the Gateway to Local Adoption series, Visions4Health caught up with James Scott, Digital and Informatics Specialist …

The UK’s Life Sciences Sector Plan: a fresh launchpad or a continued labyrinth for the uptake of innovative medicines?

August 27, 2025 Business Services, Market Access, Market Access Consultancy, Sales and Marketing NHS, Visions4Health

As the UK healthcare system navigates a period of significant change, the path to successful market access is becoming increasingly …

Single national formulary and community care: a closer look at the 10-Year Health Plan

August 21, 2025 Business Services, Market Access Gateway to Local Adoption, NHS, Visions4Health

In the fourth of the Gateway to Local Adoption series, Visions4Health caught up with Frances Smith, Clinical Pharmacy Services Manager, …

Key strategies to foster digital transformation in the NHS

July 30, 2025 Business Services, Market Access, Market Access Consultancy Corporate, Gateway to Local Adoption, NHS, Pharmacy, Visions4Health, digital transformation, pharmacy

In the third of the Gateway to Local Adoption series, Visions4Health caught up with James Scott, Digital and Informatics Specialist …

The quiet crisis: why medicines operations matter more than ever in the ICB era

July 4, 2025 Business Services, Market Access Gateway to Local Adoption, Integrated Care Board, NHS, Primary Care Networks, Visions4Health

In the second of the Gateway to Local Access series, Vision4Health caught up with Dr Graham Duce, ICB GP Prescribing …

Biocon Biologics gains EU approval for bone health therapies

July 4, 2025 Market Access, Medical Communications, Research and Development Biocon Biologics, Committee for Medicinal Products for Human USE, European Commission, Evfraxy, Oncology, Orthopaedics, Osteoporosis, Vevzuo, bone health, osteoporosis, prostate cancer

Biocon Biologics has announced that the European Commission has granted marketing authorisation for its denosumab biosimilars, Vevzuo and Evfraxy, marking …

Unlocking the gateway to โ€˜precisionโ€™ UK market access

June 27, 2025 Business Services, Market Access, Market Access Consultancy, Sales and Marketing NHS, Visions4Health

As the UK healthcare system navigates a period of significant change, the path to successful market access is becoming increasingly …

NICE recommends Pfizerโ€™s new once-weekly treatment for haemophilia B on NHS

May 22, 2025 Market Access, Research and Development Haematology, Hympavzi, NHS, NICE, Pfizer, haemophilia B, marstacimab

Walton Oaks, 21stย May 2025ย โ€“ย Pfizer Ltd announced today that the National Institute for Health and Care Excellence (NICE) has published final …

Multiple myeloma treatment approved in Japan

May 21, 2025 Market Access, Research and Development, Sales and Marketing GSK, Japan, Oncology, Orphan Drug Designation (ODD), multiple myeloma

GSKโ€™s Blenrep (belantamab mafodotin) combinations have been approved by Japanโ€™s Ministry of Health, Labour and Welfare for the treatment of …
The Gateway to Local Adoption Series

Latest content